KALA BIO (KALA) Analyst & Key Data

Analyst Consensus

Hold2 analysts

Hold

Updated Sep 12, 2026

Total Analysts2

Buy

4

Hold

6

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.57

Median Target+3088.33%

$18.25

Potential upside vs current price

DCF Value+41.96%

$0.81

Potential upside vs current price

Current Stock Price

$0.57

Median Target+3088.33%

$18.25

Potential upside vs current price

DCF Value+41.96%

$0.81

Potential upside vs current price

Analyst Consensus

Hold2 analysts

Hold

Updated Sep 12, 2026

Total Analysts2

Buy

4

Hold

6

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.57

Median Target+3088.33%

$18.25

Potential upside vs current price

DCF Value+41.96%

$0.81

Potential upside vs current price

Current Stock Price

$0.57

Median Target+3088.33%

$18.25

Potential upside vs current price

DCF Value+41.96%

$0.81

Potential upside vs current price

KALA BIO, Inc.